bupropion has been researched along with Somatoform Disorders in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papakostas, GI | 1 |
| Stahl, SM | 1 |
| Krishen, A | 1 |
| Seifert, CA | 1 |
| Tucker, VL | 1 |
| Goodale, EP | 1 |
| Fava, M | 1 |
| Davidson, J | 1 |
| Pelton, S | 1 |
1 review available for bupropion and Somatoform Disorders
| Article | Year |
|---|---|
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
Topics: Anxiety Disorders; Bupropion; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Double-Blind M | 2008 |
1 trial available for bupropion and Somatoform Disorders
| Article | Year |
|---|---|
Forms of atypical depression and their response to antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trial | 1986 |